Citation Select	DIGIT-HF Study Group; Bavendiek U, Großhennig A, Schwab J, Berliner D, Rieth A, Maier LS, Gaspar T, Thomas NH, Liu X, Schallhorn S, Angelini E, Soltani S, Rathje F, Sandu MA, Geller W, Hambrecht R, Zdravkovic M, Philipp S, Kosevic D, Nickenig G, Scheiber D, Winkler S, Becher PM, Lurz P, Hülsmann M, Wiesner S, Schröder C, Neuhaus B, Seltmann A, von der Leyen H, Veltmann C, Störk S, Böhm M, Koch A, Bauersachs J Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction N Engl J Med. 2025 Aug 29. doi: 10.1056/NEJMoa2415471
Citation Select	Baudry G, Pereira O, Roubille F, Villaceque M, Damy T, Duarte K, Tangre P, Girerd N Cardiologist follow-up and improved outcomes of heart failure: a French nationwide cohort Eur Heart J. 2025 May 18:ehaf218. doi: 10.1093/eurheartj/ehaf218. Epub ahead of print
Citation Select	Anker SD, Friede T, Butler J, Talha KM, Placzek M, Diek M, Nosko A, Stas A, Kluge S, Jarczak D, deHeer G, Rybczynski M, Bayés-Genís A, Böhm M, Coats AJS, Edelmann F, Filippatos G, Hasenfuß G, Haverkamp W, Lainscak M, Landmesser U, Macdougall IC, Merkely B, Pieske BM, Pinto FJ, Rassaf T, Visser-Rogers JK, et al Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical Trial JAMA. 2025 Mar 30:e253833. doi: 10.1001/jama.2025.3833. Epub ahead of print
Citation Select	Gabet A, Blacher J, Pousset F, Grave C, Lailler G, Tuppin P, Saadi M, Cohen A, Logeart D, Isnard R, Olié V Epidemiology of heart failure in France. Epidémiologie de l,insuffisance cardiaque en France Arch Cardiovasc Dis. 2024 Dec;117(12):705-714. doi: 10.1016/j.acvd.2024.10.004
Citation Select	Jhund PS, Talebi A, Henderson AD, Claggett BL, Vaduganathan M, Desai AS, Lam CSP, Pitt B, Senni M, Shah SJ, Voors AA, Zannad F, Solomon SD, McMurray JJV Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis Lancet. 2024 Sep 21;404(10458):1119-1131. doi: 10.1016/S0140-6736(24)01733-1
Citation Select	FINEARTS-HF Committees and Investigators; Solomon SD, McMurray JJV, Vaduganathan M, Claggett B, Jhund PS, Desai AS, Henderson AD, Lam CSP, Pitt B, Senni M, Shah SJ, Voors AA, Zannad F, Abidin IZ, Alcocer-Gamba MA, Atherton JJ, Bauersachs J, Chang-Sheng M, Chiang CE, Chioncel O, Chopra V, Comin-Colet J, Filippatos G, Fonseca C, Gajos G, Goland S, Goncalvesova E, Kang S, Katova T, Kosiborod MN, Latkovskis G, Lee AP, Linssen GCM, Llamas-Esperón G, Mareev V, Martinez FA, Melenovský V, Merkely B, Nodari S, Petrie MC, Saldarriaga CI, Saraiva JFK, Sato N, Schou M, Sharma K, Troughton R, Udell JA, Ukkonen H, Vardeny O, Verma S, von Lewinski D, Voronkov L, Yilmaz MB, Zieroth S, Lay-Flurrie J, van Gameren I, Amarante F, Kolkhof P, Viswanathan P Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction N Engl J Med. 2024 Sep 1. doi: 10.1056/NEJMoa2407107. Epub ahead of print
Citation Select	Cox ZL, Collins SP, Hernandez GA, McRae AT 3rd, Davidson BT, Adams K, Aaron M, Cunningham L, Jenkins CA, Lindsell CJ, Harrell FE Jr, Kampe C, Miller KF, Stubblefield WB, Lindenfeld J Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure J Am Coll Cardiol. 2024 Apr 9;83(14):1295-1306. doi: 10.1016/j.jacc.2024.02.009
Citation Select	Yan L, Lu Y, Deng M, Zhang Q, Bian Y, Zhou X, Hou G Efficacy of high-flow nasal cannula in patients with acute heart failure: a systematic review and meta-analysis BMC Pulm Med. 2023 Nov 28;23(1):476. doi: 10.1186/s12890-023-02782-0
Citation Select	Vaduganathan M, Mentz RJ, Claggett BL, Miao ZM, Kulac IJ, Ward JH, Hernandez AF, Morrow DA, Starling RC, Velazquez EJ, Williamson KM, Desai AS, Zieroth S, Lefkowitz M, McMurray JJV, Braunwald E, Solomon SD Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre- specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF Eur Heart J. 2023 Aug 14;44(31):2982-2993. doi: 10.1093/eurheartj/ehad344
Citation Select	Diaz-Arocutipa C, Denegri-Galvan J, Vicent L, Pariona M, Mamas MA, Hernandez AV The added value of hypertonic saline solution to furosemide monotherapy in patients with acute decompensated heart failure: A meta-analysis and trial sequential analysis Clin Cardiol. 2023 Aug;46(8):853-865. doi: 10.1002/clc.24033
Citation Select	Kittleson MM, Panjrath GS, Amancherla K, Davis LL, Deswal A, Dixon DL, Januzzi JL Jr, Yancy CW 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee J Am Coll Cardiol. 2023 May 9;81(18):1835-1878. doi: 10.1016/j.jacc.2023.03.393
Citation Select	Colin-Ramirez E, Sepehrvand N, Rathwell S, Ross H, Escobedo J, Macdonald P, Troughton R, Saldarriaga C, Lanas F, Doughty R, McAlister FA, Ezekowitz JA Sodium Restriction in Patients With Heart Failure: A Systematic Review and Meta-Analysis of Randomized Clinical Trials Circ Heart Fail. 2023 Jan;16(1):e009879. doi: 10.1161/CIRCHEARTFAILURE.122.009879
Citation Select	Mebazaa A, Davison B, Chioncel O, Cohen-Solal A, Diaz R, Filippatos G, Metra M, Ponikowski P, Sliwa K, Voors AA, Edwards C, Novosadova M, Takagi K, Damasceno A, Saidu H, Gayat E, Pang PS, Celutkiene J, Cotter G Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial Lancet. 2022 Nov 4:S0140-6736(22)02076-1. doi: 10.1016/S0140-6736(22)02076-1
Citation Select	Peikert A, Martinez FA, Vaduganathan M, Claggett BL, Kulac IJ, Desai AS, Jhund PS, de Boer RA, DeMets D, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Shah SJ, Katova T, Merkely B, Vardeny O, Wilderäng U, Lindholm D, Petersson M, Langkilde AM, McMurray JJV, Solomon SD Efficacy and Safety of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Age: The DELIVER Trial Circ Heart Fail. 2022 Oct;15(10):e010080. doi: 10.1161/CIRCHEARTFAILURE.122.010080
Citation Select	Biegus J, Voors AA, Collins SP, Kosiborod MN, Teerlink JR, Angermann CE, Tromp J, Ferreira JP, Nassif ME, Psotka MA, Brueckmann M, Salsali A, Blatchford JP, Ponikowski P Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial Eur Heart J. 2022 Oct 18:ehac530. doi: 10.1093/eurheartj/ehac530
Citation Select	DELIVER Trial Committees and Investigators; Solomon SD, McMurray JJV, Claggett B, de Boer RA, DeMets D, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, Shah SJ, Desai AS, Jhund PS, Belohlavek J, Chiang CE, Borleffs CJW, Comin-Colet J, Dobreanu D, Drozdz J, Fang JC, Alcocer-Gamba MA, Al Habeeb W, Han Y, Cabrera Honorio JW, Janssens SP, Katova T, Kitakaze M, Merkely B, O,Meara E, Saraiva JFK, Tereshchenko SN, Thierer J, Vaduganathan M, Vardeny O, Verma S, Pham VN, Wilderäng U, Zaozerska N, Bachus E, Lindholm D, Petersson M, Langkilde AM Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction N Engl J Med. 2022 Sep 22;387(12):1089-1098. doi: 10.1056/NEJMoa2206286
Citation Select	Xiang B, Zhang R, Wu X, Zhou X Optimal Pharmacologic Treatment of Heart Failure With Preserved and Mildly Reduced Ejection Fraction: A Meta-analysis JAMA Netw Open. 2022 Sep 1;5(9):e2231963. doi: 10.1001/jamanetworkopen.2022.31963
Citation Select	ADVOR Study Group; Mullens W, Dauw J, Martens P, Verbrugge FH, Nijst P, Meekers E, Tartaglia K, Chenot F, Moubayed S, Dierckx R, Blouard P, Troisfontaines P, Derthoo D, Smolders W, Bruckers L, Droogne W, Ter Maaten JM, Damman K, Lassus J, Mebazaa A, Filippatos G, Ruschitzka F, Dupont M Acetazolamide in Acute Decompensated Heart Failure with Volume Overload N Engl J Med. 2022 Aug 27. doi: 10.1056/NEJMoa2203094
Citation Select	Schulze PC, Bogoviku J, Westphal J, Aftanski P, Haertel F, Grund S, von Haehling S, Schumacher U, Möbius-Winkler S, Busch M Effects of Early Empagliflozin Initiation on Diuresis and Kidney Function in Patients With Acute Decompensated Heart Failure (EMPAG-HF) Circulation. 2022 Jul 26;146(4):289-298. doi: 10.1161/CIRCULATIONAHA.122.059038
Citation Select	EMPEROR-Preserved Trial Committees and Investigators; Böhm M, Butler J, Filippatos G, Ferreira JP, Pocock SJ, Abdin A, Mahfoud F, Brueckmann M, Gollop ND, Iwata T, Ponikowski P, Wanner C, Zannad F, Packer M, Anker SD Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age J Am Coll Cardiol. 2022 Jul 5;80(1):1-18. doi: 10.1016/j.jacc.2022.04.040
Citation Select	SODIUM-HF Investigators; Ezekowitz JA, Colin-Ramirez E, Ross H, Escobedo J, Macdonald P, Troughton R, Saldarriaga C, Alemayehu W, McAlister FA, Arcand J, Atherton J, Doughty R, Gupta M, Howlett J, Jaffer S, Lavoie A, Lund M, Marwick T, McKelvie R, Moe G, Pandey AS, Porepa L, Rajda M, Rheault H, Singh J, Toma M, Virani S, Zieroth S Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial Lancet. 2022 Apr 9;399(10333):1391-1400. doi: 10.1016/S0140-6736(22)00369-5
Citation Select	Tromp J, Ouwerkerk W, van Veldhuisen DJ, Hillege HL, Richards AM, van der Meer P, Anand IS, Lam CSP, Voors AA A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction JACC Heart Fail. 2022 Feb;10(2):73-84. doi: 10.1016/j.jchf.2021.09.004
Citation Select	Kapelios CJ, Bonou Μ, Malliaras K, Athanasiadi E, Vakrou S, Skouloudi M, Masoura C, Barbetseas J Association of loop diuretics use and dose with outcomes in outpatients with heart failure: a systematic review and meta-analysis of observational studies involving 96,959 patients Heart Fail Rev. 2022 Jan;27(1):147-161. doi: 10.1007/s10741-020-09995-z
Citation Select	Fudim M, Spates T, Sun JL, Kittipibul V, Testani JM, Starling RC, Tang WHW, Hernandez AF, Felker GM, O,Connor CM, Mentz RJ Early diuretic strategies and the association with In-hospital and Post-discharge outcomes in acute heart failure Am Heart J. 2021 Sep;239:110-119. doi: 10.1016/j.ahj.2021.05.011
Citation Select	EMPEROR-Preserved Trial Investigators; Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Böhm M, Brunner-La Rocca HP, Choi DJ, Chopra V, Chuquiure-Valenzuela E, Giannetti N, Gomez-Mesa JE, Janssens S, Januzzi JL, Gonzalez-Juanatey JR, Merkely B, Nicholls SJ, Perrone SV, Piña IL, Ponikowski P, Senni M, Sim D, Spinar J, Squire I, Taddei S, Tsutsui H, Verma S, Vinereanu D, Zhang J, Carson P, Lam CSP, Marx N, Zeller C, Sattar N, Jamal W, Schnaidt S, Schnee JM, Brueckmann M, Pocock SJ, Zannad F, Packer M Empagliflozin in Heart Failure with a Preserved Ejection Fraction N Engl J Med. 2021 Aug 27. doi: 10.1056/NEJMoa2107038. Epub ahead of print
Citation Select	Liu C, Peng Z, Gao X, Gajic O, Dong Y, Prokop LJ, Murad MH, Kashani KB, Domecq JP Simultaneous Use of Hypertonic Saline and IV Furosemide for Fluid Overload: A Systematic Review and Meta-Analysis Crit Care Med. 2021 Jun 24. doi: 10.1097/CCM.0000000000005174. Online ahead of print
Citation Select	Martin N, Manoharan K, Davies C, Lumbers RT Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction Cochrane Database Syst Rev. 2021 May 22;5(5):CD012721. doi: 10.1002/14651858.CD012721.pub3
Citation Select	Kitzman DW, Whellan DJ, Duncan P, Pastva AM, Mentz RJ, Reeves GR, Nelson MB, Chen H, Upadhya B, Reed SD, Espeland MA, Hewston L, O,Connor CM Physical Rehabilitation for Older Patients Hospitalized for Heart Failure N Engl J Med. 2021 Jul 15;385(3):203-216. doi: 10.1056/NEJMoa2026141
Citation Select	Yonathan Freund, Marine Cachanado, Quentin Delannoy, Said Laribi, Youri Yordanov, Judith Gorlicki, Tahar Chouihed, Anne-Laure Féral-Pierssens, Jennifer Truchot, Thibaut Desmettre, Celine Occelli, Xavier Bobbia, Mehdi Khellaf, Olivier Ganansia, Jérôme Bokobza, Frédéric Balen, Sebastien Beaune, Ben Bloom, Tabassome Simon, Alexandre Mebazaa Effect of an Emergency Department Care Bundle on 30-Day Hospital Discharge and Survival Among Elderly Patients With Acute Heart Failure: The ELISABETH Randomized Clinical Trial JAMA. 2020 Nov 17;324(19):1948-1956. doi: 10.1001/jama.2020.19378.
Citation Select	Packer , Anker , Butler , Filippatos , Pocock , Carson , Januzzi , Verma , Tsutsui , Brueckmann , Jamal , Kimura , Schnee , Zeller , Cotton , Bocchi , Böhm , Choi , Chopra , Chuquiure , Giannetti , Janssens , Zhang , Gonzalez Juanatey , Kaul , Brunner-La Rocca , Merkely , Nicholls , Perrone , Pina , Ponikowski , Sattar , Senni , Seronde , Spinar , Squire , Taddei , Wanner , Zannad , EMPEROR-Reduced Trial Investigators , Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N Engl J Med. 2020 Oct 8;383(15):1413-1424. doi: 10.1056/NEJMoa2022190
Citation Select	VICTORIA Study Group; Paul W Armstrong, Burkert Pieske, Kevin J Anstrom, Justin Ezekowitz, Adrian F Hernandez, Javed Butler, Carolyn S P Lam, Piotr Ponikowski, Adriaan A Voors, Gang Jia, Steven E McNulty, Mahesh J Patel, Lothar Roessig, Joerg Koglin, Christopher M O,Connor Vericiguat in Patients With Heart Failure and Reduced Ejection Fraction N Engl J Med. 2020 May 14;382(20):1883-1893
Citation Select	Simone Frea, Stefano Pidello, Alessandra Volpe, Federico Giovanni Canavosio, Alessandro Galluzzo, Virginia Bovolo, Antonio Camarda, Pier Giorgio Golzio, Fabrizio D,Ascenzo, Serena Bergerone, Mauro Rinaldi, Fiorenzo Gaita Diuretic treatment in high-risk acute decompensation of advanced chronic heart failure-bolus intermittent vs. continuous infusion of furosemide: a randomized controlled trial Clin Res Cardiol. 2020 Apr;109(4):417-425. doi: 10.1007/s00392-019-01521-y. Epub 2019 Jun 29.
Citation Select	Oh GC, Cho HJ, Lee SE, Kim MS, Kim JJ, Choi JO, Jeon ES, Hwang KK, Chae SC, Baek SH, Kang SM, Yoo BS, Choi DJ, Ahn Y, Kim KH, Cho MC, Oh BH, Lee HY Management and Prognosis of Heart Failure in Octogenarians: Final Report from the KorAHF Registry J Clin Med. 2020 Feb 12;9(2):501. doi: 10.3390/jcm9020501
Citation Select	DAPA-HF Trial Committees and Investigators; McMurray JJV, Solomon SD, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, Bělohlávek J, Böhm M, Chiang CE, Chopra VK, de Boer RA, Desai AS, Diez M, Drozdz J, Dukát A, Ge J, Howlett JG, Katova T, Kitakaze M, Ljungman CEA, Merkely B, Nicolau JC, O'Meara E, Petrie MC, Vinh PN, Schou M, Tereshchenko S, Verma S, Held C, DeMets DL, Docherty KF, Jhund PS, Bengtsson O, Sjöstrand M, Langkilde AM Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction N Engl J Med. 2019 Nov 21;381(21):1995-2008. doi: 10.1056/NEJMoa1911303
Citation Select	PARAGON-HF Investigators and Committees; Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, van Veldhuisen DJ, Zannad F, Zile MR, Desai AS, Claggett B, Jhund PS, Boytsov SA, Comin-Colet J, Cleland J, Düngen HD, Goncalvesova E, Katova T, Kerr Saraiva JF, Lelonek M, Merkely B, Senni M, Shah SJ, Zhou J, Rizkala AR, Gong J, Shi VC, Lefkowitz MP Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction N Engl J Med. 2019 Oct 24;381(17):1609-1620. doi: 10.1056/NEJMoa1908655
Citation Select	Taylor RS, Walker S, Ciani O, Warren F, Smart NA, Piepoli M5, Davos CH Exercise-based cardiac rehabilitation for chronic heart failure: the EXTRAMATCH II individual participant data meta-analysis Health Technol Assess. 2019 May;23(25):1-98
Citation Select	Palmer K, Bowles KA, Paton M, Jepson M, Lane R Chronic Heart Failure and Exercise Rehabilitation: A Systematic Review and Meta-Analysis Arch Phys Med Rehabil. 2018 Dec;99(12):2570-2582
Citation Select	Shah KS, Xu H, Matsouaka RA, Bhatt DL, Heidenreich PA, Hernandez AF, Devore AD, Yancy CW, Fonarow GC Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes J Am Coll Cardiol. 2017 Nov 14;70(20):2476-2486. doi: 10.1016/j.jacc.2017.08.074
Citation Select	Stienen Salah Moons Bakx van Pol Kortz Ferreira Marques Schroeder-Tanka Keijer Bayés-Genis Tijssen Pinto Kok NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial Circulation. 2018 Apr 17;137(16):1671-1683
Citation Select	Zheng SL, Chan FT, Nabeebaccus AA, Shah AM, McDonagh T, Okonko DO, Ayis S Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis Heart. 2018 Mar;104(5):407-415. doi: 10.1136/heartjnl-2017-311652
Citation Select	Faris RF, Flather M, Purcell H, Poole-Wilson PA, Coats AJ WITHDRAWN: Diuretics for heart failure Cochrane Database Syst Rev. 2016 Apr 4;4(4):CD003838. doi: 10.1002/14651858.CD003838.pub4
Citation Select	Martindale Wakai Collins Levy Diercks Hiestand Fermann deSouza Sinert Diagnosing Acute Heart Failure in the Emergency Department: A Systematic Review and Meta-analysis. Acad Emerg Med. 2016 Mar;23(3):223-42
Citation Select	PARADIGM-HF Investigators and Committees; McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR Angiotensin-neprilysin inhibition versus enalapril in heart failure N Engl J Med. 2014 Sep 11;371(11):993-1004. doi: 10.1056/NEJMoa1409077
Citation Select	Goldenberg I, Kutyifa V, Klein HU, Cannom DS, Brown MW, Dan A, Daubert JP, Estes 3rd, Foster E, Greenberg H, Kautzner J, Klempfner R, Kuniss M, Merkely B, Pfeffer MA, Quesada A, Viskin S, McNitt S, Polonsky B, Ghanem A, Solomon SD, Wilber D, Zareba W, Moss AJ Survival with cardiac-resynchronization therapy in mild heart failure N Engl J Med. 2014 May 1;370(18):1694-701
Citation Select	TOPCAT Investigators, Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Harty B, Heitner JF, Kenwood CT, Lewis EF, O,Meara E, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, Yang S, McKinlay SM Spironolactone for heart failure with preserved ejection fraction N Engl J Med. 2014 Apr 10;370(15):1383-92
Citation Select	Tuppin Cuerq de Peretti Fagot-Campagna Danchin Juillière Alla Allemand Bauters Drici Hagège Jondeau Jourdain Leizorovicz Paccaud Two-year outcome of patients after a first hospitalization for heart failure: A national observational study. Arch Cardiovasc Dis. 2014 Mar;107(3):158-68
Citation Select	Liu F, Chen Y, Feng X, Teng Z, Yuan Y, Bin J Effects of beta-blockers on heart failure with preserved ejection fraction: a meta-analysis PLoS One. 2014;9(3):e90555
Citation Select	Makani H, Bangalore S, Desouza KA, Shah A, Messerli FH, Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials. BMJ. 2013 Jan 28;346:f360. doi: 10.1136/bmj.f360.
Citation Select	Takeda A, Taylor SJ, Taylor RS, Khan F, Krum H, Underwood M Clinical service organisation for heart failure Cochrane Database Syst Rev. 2012;9:CD002752
Citation Select	Stewart S, Carrington MJ, Marwick TH, Davidson PM, Macdonald P, Horowitz JD, Krum H, Newton PJ, Reid C, Chan YK, Scuffham PA, Impact of Home Versus Clinic-Based Management of Chronic Heart Failure: The WHICH? (Which Heart Failure Intervention Is Most Cost-Effective ? Consumer Friendly in Reducing Hospital Care) Multicenter, Randomized Trial. J Am Coll Cardiol. 2012 Oct 2;60(14):1239-48
Citation Select	Januzzi Jr, Rehman SU, Mohammed AA, Bhardwaj A, Barajas L, Barajas J, Kim HN, Baggish AL, Weiner RB, Chen-Tournoux A, Marshall JE, Moore SA, Carlson WD, Lewis GD, Shin J, Sullivan D, Parks K, Wang TJ, Gregory SA, Uthamalingam S, Semigran MJ Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction J Am Coll Cardiol. 2011 Oct 25;58(18):1881-9
Citation Select	Holland DJ, Kumbhani DJ, Ahmed SH, Marwick TH, Effects of treatment on exercise tolerance, cardiac function, and mortality in heart failure with preserved ejection fraction. A meta-analysis. J Am Coll Cardiol. 2011 Apr 19;57(16):1676-86
Citation Select	Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Braunwald E, O,Connor CM, NHLBI Heart Failure Clinical Research Network NHLBI Heart Failure Clinical Research Network, Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011 Mar 3;364(9):797-805. doi: 10.1056/NEJMoa1005419
Citation Select	EMPHASIS-HF Study Group, Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med. 2011 Jan 6;364(1):11-21
Citation Select	Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators, Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, Nichol G, Birnie DH, Sapp JL, Yee R, Healey JS, Rouleau JL Cardiac-resynchronization therapy for mild-to-moderate heart failure N Engl J Med. 2010 Dec 16;363(25):2385-95
Citation Select	Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L, SHIFT Investigators SHIFT Investigators, Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010 Sep 11;376(9744):875-85
Citation Select	Desai A, Lewis E, Solomon S, McMurray JJ, Pfeffer M, Impact of erythropoiesis-stimulating agents on morbidity and mortality in patients with heart failure: an updated, post-TREAT meta-analysis. Eur J Heart Fail. 2010 Sep;12(9):936-42
Citation Select	Porapakkham P, Porapakkham P, Zimmet H, Billah B, Krum H B-type natriuretic peptide-guided heart failure therapy: A meta-analysis Arch Intern Med. 2010 Mar 22;170(6):507-14
Citation Select	Berger R, Moertl D, Peter S, Ahmadi R, Huelsmann M, Yamuti S, Wagner B, Pacher R N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study J Am Coll Cardiol. 2010 Feb 16;55(7):645-53
Citation Select	Ngo K, Kotecha D, Walters JA, Manzano L, Palazzuoli A, van Veldhuisen DJ, Flather M Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients Cochrane Database Syst Rev. 2010;1(1):CD007613
Citation Select	Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W, MADIT-CRT Trial Investigators MADIT-CRT Trial Investigators, Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009 Oct 1;361(14):1329-38
Citation Select	B-CONVINCED Investigators; Jondeau G, Neuder Y, Eicher JC, Jourdain P, Fauveau E, Galinier M, Jegou A, Bauer F, Trochu JN, Bouzamondo A, Tanguy ML, Lechat P B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode Eur Heart J. 2009 Sep;30(18):2186-92
Citation Select	Somaratne JB, Berry C, McMurray JJ, Poppe KK, Doughty RN, Whalley GA The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis Eur J Heart Fail. 2009 Sep;11(9):855-62
Citation Select	SENIORS Investigators, van Veldhuisen DJ, Cohen-Solal A, Böhm M, Anker SD, Babalis D, Roughton M, Coats AJ, Poole-Wilson PA, Flather MD Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure) J Am Coll Cardiol. 2009 Jun 9;53(23):2150-8
Citation Select	Maestre A, Gil V, Gallego J, Aznar J, Mora A, Martín-Hidalgo A, Diagnostic accuracy of clinical criteria for identifying systolic and diastolic heart failure: cross-sectional study. J Eval Clin Pract. 2009 Feb;15(1):55-61
Citation Select	Jhund PS, Macintyre K, Simpson CR, Lewsey JD, Stewart S, Redpath A, Chalmers JW, Capewell S, McMurray JJ Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people Circulation. 2009 Feb 3;119(4):515-23
Citation Select	Hernandez AF, Hammill BG, O,Connor CM, Schulman KA, Curtis LH, Fonarow GC Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry J Am Coll Cardiol. 2009 Jan 13;53(2):184-92. doi: 10.1016/j.jacc.2008.09.031
Citation Select	Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, Vuillomenet A, Jeker U, Dubach P, Beer H, Yoon SI, Suter T, Osterhues HH, Schieber MM, Hilti P, Schindler R, Brunner-La Rocca HP, TIME-CHF Investigators TIME-CHF Investigators, BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial. JAMA. 2009 Jan 28;301(4):383-92
Citation Select	3CPO Trialists; Gray A, Goodacre S, Newby DE, Masson M, Sampson F, Nicholl J Noninvasive ventilation in acute cardiogenic pulmonary edema N Engl J Med. 2008 Jul 10;359(2):142-51
Citation Select	Phillips CO, Kashani A, Ko DK, Francis G, Krumholz HM Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials Arch Intern Med. 2007 Oct 8;167(18):1930-6
Citation Select	Remme WJ, Torp-Pedersen C, Cleland JG, Poole-Wilson PA, Metra M, Komajda M, Swedberg K, Di Lenarda A, Spark P, Scherhag A, Moullet C, Lukas MA, Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET. J Am Coll Cardiol. 2007 Mar 6;49(9):963-71
Citation Select	Goldberg RJ, Ciampa J, Lessard D, Meyer TE, Spencer FA Long-term survival after heart failure: a contemporary population-based perspective Arch Intern Med. 2007 Mar 12;167(5):490-6
Citation Select	PEP-CHF Investigators, Cleland JG, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J The perindopril in elderly people with chronic heart failure (PEP-CHF) study Eur Heart J. 2006 Oct;27(19):2338-45
Citation Select	Ahmed A, Rich MW, Fleg JL, Zile MR, Young JB, Kitzman DW, Love TE, Aronow WS, Adams KF Jr, Gheorghiade M Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial Circulation. 2006 Aug 1;114(5):397-403. Epub 2006 Jul 24
Citation Select	Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, Gong Y, Liu PP Outcome of heart failure with preserved ejection fraction in a population-based study N Engl J Med. 2006 Jul 20;355(3):260-9
Citation Select	Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med. 2006 Jul 20;355(3):251-9
Citation Select	Ahmed A, Husain A, Love TE, Gambassi G, Dell,italia LJ, Francis GS, Gheorghiade M, Allman RM, Meleth S, Bourge RC Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods Eur Heart J. 2006 Jun;27(12):1431-1439. Epub 2006 May 18
Citation Select	Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton P, Sullivan MD, Pitt B, Poole-Wilson PA, Mann DL, Packer M, The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006 Mar 21;113(11):1424-33
Citation Select	Wang CS, FitzGerald JM, Schulzer M, Mak E, Ayas NT Does this dyspneic patient in the emergency department have congestive heart failure? JAMA. 2005 Oct 19;294(15):1944-56
Citation Select	Sanders GD, Hlatky MA, Owens DK Cost-effectiveness of implantable cardioverter-defibrillators N Engl J Med. 2005 Oct 6;353(14):1471-80
Citation Select	EPHESUS Investigators; Pitt B, White H, Nicolau J, Martinez F, Gheorghiade M, Aschermann M, van Veldhuisen DJ, Zannad F, Krum H, Mukherjee R, Vincent J Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure J Am Coll Cardiol. 2005 Aug 2;46(3):425-31
Citation Select	Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators; Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med. 2005 Apr 14;352(15):1539-49
Citation Select	SENIORS Investigators, Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Soler-Soler J, Tavazzi L, Spinarova L, Toman J, Böhm M, Anker SD, Thompson SG, Poole-Wilson PA Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) Eur Heart J. 2005 Feb;26(3):215-25
Citation Select	Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH Amiodarone or an Implantable Cardioverter-Defibrillator for Congestive Heart Failure N Engl J Med. 2005 Jan 20;352(3):225-237
Citation Select	Desai AS, Fang JC, Maisel WH, Baughman KL Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials JAMA. 2004 Dec 15;292(23):2874-9
Citation Select	African-American Heart Failure Trial Investigators; Taylor AL, Ziesche S, Yancy C, Carson P, D,Agostino R Jr, Ferdinand K, Taylor M, Adams K, Sabolinski M, Worcel M, Cohn JN Combination of isosorbide dinitrate and hydralazine in blacks with heart failure N Engl J Med. 2004 Nov 11;351(20):2049-57. Epub 2004 Nov 8
Citation Select	Lee VC, Rhew DC, Dylan M, Badamgarav E, Braunstein GD, Weingarten SR Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction Ann Intern Med. 2004 Nov 2;141(9):693-704
Citation Select	Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators; Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med. 2004 May 20;350(21):2140-50
Citation Select	Nanas JN, Tsagalou EP, Kanakakis J, Nanas SN, Terrovitis JV, Moon T, Anastasiou-Nana MI Long-term intermittent dobutamine infusion, combined with oral amiodarone for end-stage heart failure: a randomized double-blind study Chest. 2004 Apr;125(4):1198-204
Citation Select	Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, Pfisterer M, Perruchoud AP Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea N Engl J Med. 2004 Feb 12;350(7):647-54
Citation Select	Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J; CHARM Investigators and Committees Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Lancet. 2003 Sep 6;362(9386):777-81
Citation Select	Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K; CHARM Investigators and Committees Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial Lancet. 2003 Sep 6;362(9386):772-6
Citation Select	McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL, Olofsson B, Yusuf S, Pfeffer MA; CHARM Investigators and Committees Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial Lancet. 2003 Sep 6;362(9386):767-71
Citation Select	Breathing Not Properly Multinational Study Investigators; Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med. 2002 Jul 18;347(3):161-7
Citation Select	Feenstra J, Heerdink ER, Grobbee DE, Stricker BH Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study Arch Intern Med. 2002 Feb 11;162(3):265-70
Citation Select	Lynn Caruana, Mark C Petrie, Andrew P Davie, John J V McMurray Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study BMJ. 2000 Jul 22;321(7255):215-8
Citation Select	Flather MD, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G, Torp-Pedersen C, Ball S, Pogue J, Moye L, Braunwald E Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group Lancet. 2000 May 6;355(9215):1575-1581
Citation Select	Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, Konstam MA, Riegger G, Klinger GH, Neaton J, Sharma D, Thiyagarajan B, on behalf of the ELITE II investigators Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial. The Losartan Heart Failure Survival Study ELITE II Lancet. 2000 May 6;355(9215):1582-1587
Citation Select	Page J, Henry D Consumption of NSAIDs and the Development of Congestive Heart Failure in Elderly Patients. An Underrecognized Public Health Problem Arch Intern Med. 2000 Mar 27;160(6):777-784
Citation Select	Hjalmarson A, Goldstein S, Fagerberg B, et al., for the MERIT-HF Study Group Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF) JAMA. 2000 Mar 8;283(10):1295-302
Citation Select	Bertram Pitt, Faiez Zannad, Willem J. Remme, Robert Cody, Alain Castaigne, Alfonso Perez, Jolie Palensky, Janet Wittes The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure. Randomized Aldactone Evaluation Study (RALES) Investigators N Engl J Med. 1999 Sept 2;341(10):709-17
Citation Select	Belardinelli R, Georgiou D, Cianci G, Purcaro A Randomized, controlled trial of long-term moderate exercise training in chronic heart failure. Effects on functional capacity, quality of life, and clinical outcome Circulation. 1999 Mar 9;99:1173-82
Citation Select	Harf C, Welter R Emergency treatment of severe cardiogenic pulmonary edema with intravenous isosorbide-5-mononitrate Am J Cardiol. 1988 Mar 25;61(9):22E-27E
Citation Select	Cotter G, Metzkor E, Kaluski E, Faigenberg Z, Miller R, Simovitz A, Shaham O, Marghitay D, Koren M, Blatt A, Moshkovitz Y, Zaidenstein R, Golik A Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet. 1998 Feb 7;351(9100):389-93
Citation Select	Philippe Lechat, Milton Packer, Stephan Chalon, Michel Cucherat, Tarek Arab, Jean-Pierre Boissel Clinical Effects of ß-Adrenergic Blockade in Chronic Heart Failure. A Meta-Analysis of Double-Blind, Placebo-Controlled, Randomized Trials Circulation. 1998;98:1184-1191.
Citation Select	Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Ney DE, Snavely DB, Chang PI Randomised trial of losartan versus captopril in patients over 65 with heart failure. Evaluation of Losartan in the Elderly Study, ELITE-I Lancet. 1997 Mar 15;349(9054):747-52
Citation Select	Australia/New Zealand Heart Failure Research Collaborative Group Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease Lancet. 1997 Feb 8;349(9049):375-80
Citation Select	Garg R, Gorlin R, Smith T, Yusuf S, for the Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group N Engl J Med. 1997 Feb 20;336(8):525-33
Citation Select	Packer M, O'Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, Miller AB, Neuberg GW, Frid D, Wertheimer JH, Cropp AB, DeMets DL Effect of amlodipine on morbidity and mortality in severe chronic heart failure. PRAISE (Prospective Randomized Amlodipine Survival Evaluation) N Engl J Med. 1996 Oct 10;335(15):1107-14
Citation Select	Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group N Engl J Med. 1996 May 23;334(21):1349-55